K.C. Pharmaceuticals Initiates Nationwide Recall of Over 3.1 Million Eye Drop Bottles Due to Sterility Concerns
K.C. Pharmaceuticals, Inc., based in Pomona, California, has voluntarily recalled over 3.1 million bottles of eye drops distributed nationwide. The recall was initiated on March 3, 2026, following concerns about the sterility of the products. The U.S. Food and Drug Administration (FDA) has classified the recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences, with the probability of serious health effects considered remote. The affected products were sold under multiple brand names through major retailers such as Walgreens, Kroger, CVS, and others. The recall includes various types of eye drops, such as Sterile Eye Drops AC, Eye Drops Advanced Relief, and Dry Eye Relief Eye Drops, among others. 
